SG181694G - Solid oral administration forms containing ifosfamide as active agent - Google Patents

Solid oral administration forms containing ifosfamide as active agent

Info

Publication number
SG181694G
SG181694G SG181694A SG181694A SG181694G SG 181694 G SG181694 G SG 181694G SG 181694 A SG181694 A SG 181694A SG 181694 A SG181694 A SG 181694A SG 181694 G SG181694 G SG 181694G
Authority
SG
Singapore
Prior art keywords
active agent
oral administration
solid oral
forms containing
administration forms
Prior art date
Application number
SG181694A
Other languages
English (en)
Inventor
Dieter Sauerbier
Jorgen Dr Deengel
Eckhard Dr Demilsmann
Klaus Dr Molge
Otto Dr Isaac
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RO148008A priority Critical patent/RO113611B1/ro
Priority to AT91112368T priority patent/ATE110261T1/de
Priority to DK91112368.5T priority patent/DK0469440T3/da
Priority to MC912206A priority patent/MC2274A1/xx
Priority to US07/733,756 priority patent/US5158776A/en
Priority to DE59102620T priority patent/DE59102620D1/de
Priority to EP91112368A priority patent/EP0469440B1/de
Priority to ES91112368T priority patent/ES2058999T3/es
Priority to DE4124481A priority patent/DE4124481A1/de
Priority to MX9100441A priority patent/MX9100441A/es
Priority to JP3191414A priority patent/JP3061898B2/ja
Priority to PT98532A priority patent/PT98532B/pt
Priority to BG94934A priority patent/BG60900B1/bg
Priority to EG46991A priority patent/EG19690A/xx
Priority to SI9111342A priority patent/SI9111342B/sl
Priority to NZ239222A priority patent/NZ239222A/xx
Priority to IL9903191A priority patent/IL99031A/en
Priority to ZA916124A priority patent/ZA916124B/xx
Priority to FI913710A priority patent/FI97951C/fi
Priority to CS912409A priority patent/CZ280475B6/cs
Priority to KR1019910013365A priority patent/KR0177170B1/ko
Priority to AR91320329A priority patent/AR247484A1/es
Priority to IE277491A priority patent/IE66378B1/en
Priority to HU912594A priority patent/HU206268B/hu
Priority to NO913019A priority patent/NO178252C/no
Priority to CN91105271A priority patent/CN1046851C/zh
Priority to SK2409-91A priority patent/SK279740B6/sk
Priority to CA002048367A priority patent/CA2048367C/en
Priority to AU81589/91A priority patent/AU643309B2/en
Priority to HRP-1342/91A priority patent/HRP920575B1/xx
Priority to LVP-92-172A priority patent/LV10043B/lv
Priority to AU44836/93A priority patent/AU649184B2/en
Priority to LTIP921A priority patent/LT3528B/lt
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Priority to SG181694A priority patent/SG181694G/en
Priority to HK15695A priority patent/HK15695A/xx
Publication of SG181694G publication Critical patent/SG181694G/en
Priority to SK543-98A priority patent/SK279739B6/sk
Priority to JP2000006836A priority patent/JP3545300B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG181694A 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent SG181694G (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
RO148008A RO113611B1 (ro) 1990-08-03 1991-07-15 Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
ES91112368T ES2058999T3 (es) 1990-08-03 1991-07-24 Formas de administracion orales solidas que contienen ifosfamida como sustancia activa.
MC912206A MC2274A1 (fr) 1990-08-03 1991-07-24 Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active
US07/733,756 US5158776A (en) 1990-08-03 1991-07-24 Solid oral dosage forms of ifosfamide
DE59102620T DE59102620D1 (de) 1990-08-03 1991-07-24 Feste orale Applikationsformen, die als Wirkstoff Ifosfamid enthalten.
EP91112368A EP0469440B1 (de) 1990-08-03 1991-07-24 Feste orale Applikationsformen, die als Wirkstoff Ifosfamid enthalten
DE4124481A DE4124481A1 (de) 1990-08-03 1991-07-24 Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten
AT91112368T ATE110261T1 (de) 1990-08-03 1991-07-24 Feste orale applikationsformen, die als wirkstoff ifosfamid enthalten.
DK91112368.5T DK0469440T3 (da) 1990-08-03 1991-07-24 Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
MX9100441A MX9100441A (es) 1990-08-03 1991-07-30 Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo
JP3191414A JP3061898B2 (ja) 1990-08-03 1991-07-31 固体の経口用イフォスファミド医薬組成物およびその製造法
BG94934A BG60900B1 (bg) 1990-08-03 1991-08-01 Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество
EG46991A EG19690A (en) 1990-08-03 1991-08-01 Solid oral forms of application containing ifosamide as active substance
SI9111342A SI9111342B (sl) 1990-08-03 1991-08-01 Trdne aplikacijske oblike, ki vsebujejo kot aktivno snov ifosfamid in postopek za njihovo proizvodnjo
NZ239222A NZ239222A (en) 1990-08-03 1991-08-01 Pharmaceutical capsules and tablets containing ifosfamide
IL9903191A IL99031A (en) 1990-08-03 1991-08-01 Solid oral pharmaceutical compositions containing ifosfamide
PT98532A PT98532B (pt) 1990-08-03 1991-08-01 Processo para a preparacao de formulacoes solidas para aplicacao oral contendo como ingrediente activo ifosfamida
ZA916124A ZA916124B (en) 1990-08-03 1991-08-02 Solid oral forms of application containing ifosfamide as active substance
CS912409A CZ280475B6 (cs) 1990-08-03 1991-08-02 Pevné formy pro orální aplikaci, které jako účinnou látku obsahující ifosfamid
KR1019910013365A KR0177170B1 (ko) 1990-08-03 1991-08-02 활성물질로서 이포스파미드를 함유하는 경구투여용 고체 제형
AR91320329A AR247484A1 (es) 1990-08-03 1991-08-02 Procedimiento para la fabricacion de preparados solidos de ifosfamida de aplicacion oral
IE277491A IE66378B1 (en) 1990-08-03 1991-08-02 Solid oral forms of application containing ifosfamide as active substance
HU912594A HU206268B (en) 1990-08-03 1991-08-02 Process for producing solid oral forms comprising iphosphamide as active ingredient
NO913019A NO178252C (no) 1990-08-03 1991-08-02 Fremgangsmåte for fremstilling av nye, faste, oralt administrerbare ifosfamidpreparater
CN91105271A CN1046851C (zh) 1990-08-03 1991-08-02 异环磷酰胺为活性成份的固体口服制剂的制备方法
SK2409-91A SK279740B6 (sk) 1990-08-03 1991-08-02 Spôsob výroby
CA002048367A CA2048367C (en) 1990-08-03 1991-08-02 Solid oral forms of application containing ifosfamide as active substance
FI913710A FI97951C (fi) 1990-08-03 1991-08-02 Menetelmä kiinteiden oraalisesti käytettävien ifosfamidivalmisteiden valmistamiseksi
AU81589/91A AU643309B2 (en) 1990-08-03 1991-08-02 Solid oral forms of application containing ifosfamide as active substance
HRP-1342/91A HRP920575B1 (en) 1990-08-03 1992-09-29 Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same
LVP-92-172A LV10043B (en) 1990-08-03 1992-10-27 Stable preparation on the basis of yphosphamide and method for producung thereof
AU44836/93A AU649184B2 (en) 1990-08-03 1993-08-23 Solid oral tablet formulations of ifosfamide
LTIP921A LT3528B (en) 1990-08-03 1993-09-03 Solid preparation based on iphosphamide and method for preparing them
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent
HK15695A HK15695A (en) 1990-08-03 1995-02-06 Solid oral administration forms containing ifosfamide as active agent
SK543-98A SK279739B6 (sk) 1990-08-03 1998-04-27 Pevné ifosfamidové prípravky na orálnu aplikáciu a
JP2000006836A JP3545300B2 (ja) 1990-08-03 2000-01-14 固体の経口用イフォスファミド医薬組成物およびその製造法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
SG181694G true SG181694G (en) 1995-05-12

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Country Status (33)

Country Link
US (1) US5158776A (cs)
EP (1) EP0469440B1 (cs)
JP (2) JP3061898B2 (cs)
KR (1) KR0177170B1 (cs)
CN (1) CN1046851C (cs)
AR (1) AR247484A1 (cs)
AT (1) ATE110261T1 (cs)
AU (2) AU643309B2 (cs)
BG (1) BG60900B1 (cs)
CA (1) CA2048367C (cs)
CZ (1) CZ280475B6 (cs)
DE (2) DE4124481A1 (cs)
DK (1) DK0469440T3 (cs)
EG (1) EG19690A (cs)
ES (1) ES2058999T3 (cs)
FI (1) FI97951C (cs)
HK (1) HK15695A (cs)
HR (1) HRP920575B1 (cs)
HU (1) HU206268B (cs)
IE (1) IE66378B1 (cs)
IL (1) IL99031A (cs)
LT (1) LT3528B (cs)
LV (1) LV10043B (cs)
MC (1) MC2274A1 (cs)
MX (1) MX9100441A (cs)
NO (1) NO178252C (cs)
NZ (1) NZ239222A (cs)
PT (1) PT98532B (cs)
RO (1) RO113611B1 (cs)
SG (1) SG181694G (cs)
SI (1) SI9111342B (cs)
SK (2) SK279740B6 (cs)
ZA (1) ZA916124B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
CN114010629A (zh) 2014-01-06 2022-02-08 英国神盾Tx股份有限公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987204A (en) 1972-09-15 1976-10-19 Sucrest Corporation Direct compression vehicle
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
ATE66609T1 (de) * 1986-07-11 1991-09-15 Asta Pharma Ag Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
IL99031A (en) 1996-09-04
KR920003963A (ko) 1992-03-27
HU206268B (en) 1992-10-28
FI97951B (fi) 1996-12-13
CS240991A3 (en) 1992-03-18
SI9111342A (sl) 1998-04-30
KR0177170B1 (ko) 1999-03-20
JP2000229860A (ja) 2000-08-22
IE66378B1 (en) 1995-12-27
DE59102620D1 (de) 1994-09-29
CN1046851C (zh) 1999-12-01
SK279740B6 (sk) 1999-03-12
RO113611B1 (ro) 1998-09-30
EG19690A (en) 1995-09-30
NO913019D0 (no) 1991-08-02
SI9111342B (sl) 1998-10-31
JP3545300B2 (ja) 2004-07-21
MC2274A1 (fr) 1993-06-23
AU649184B2 (en) 1994-05-12
US5158776A (en) 1992-10-27
CA2048367C (en) 2000-05-23
ATE110261T1 (de) 1994-09-15
HK15695A (en) 1995-02-10
SK279739B6 (sk) 1999-03-12
JP3061898B2 (ja) 2000-07-10
NO913019L (no) 1992-02-04
BG60900B1 (bg) 1996-06-28
IE912774A1 (en) 1992-02-12
EP0469440B1 (de) 1994-08-24
JPH04243828A (ja) 1992-08-31
LV10043A (lv) 1994-05-10
CZ280475B6 (cs) 1996-01-17
PT98532A (pt) 1992-06-30
MX9100441A (es) 1992-04-01
DK0469440T3 (da) 1994-11-14
CA2048367A1 (en) 1992-02-04
NO178252C (no) 1996-02-21
HRP920575B1 (en) 1999-04-30
NO178252B (no) 1995-11-13
HRP920575A2 (en) 1995-04-30
CN1058715A (zh) 1992-02-19
NZ239222A (en) 1993-01-27
ZA916124B (en) 1992-04-29
LTIP921A (en) 1995-03-27
AU4483693A (en) 1993-11-11
EP0469440A1 (de) 1992-02-05
PT98532B (pt) 1999-01-29
HU912594D0 (en) 1992-01-28
DE4124481A1 (de) 1992-02-06
BG94934A (bg) 1993-12-24
LT3528B (en) 1995-11-27
FI913710A0 (fi) 1991-08-02
AU643309B2 (en) 1993-11-11
LV10043B (en) 1995-06-20
AR247484A1 (es) 1995-01-31
AU8158991A (en) 1992-02-06
FI97951C (fi) 1997-03-25
FI913710L (fi) 1992-02-04
IL99031A0 (en) 1992-07-15
HUT59316A (en) 1992-05-28
ES2058999T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
IL82924A0 (en) Sustained release pharmaceutical compositions containing katotifen
PT86000A (en) Pharmaceutically active compounds
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
HUT43233A (en) Synergic insecticidal compositions comprising active substance combination
HUT71131A (en) Paramycin formulations for oral administration
SG181694G (en) Solid oral administration forms containing ifosfamide as active agent
PL307469A1 (en) Preparation for oral administration
EP0294053A3 (en) Physiologically active agent for agricultural use
EP0137234A3 (en) Physiologically active compositions
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
GB2195893B (en) Sustained release pharmaceutical compositions
ZA882961B (en) Oral compositions comprising anti-calculus agents
GB2274273B (en) Medicament pack
IL70771A0 (en) Pharmaceutical compositions containing nafazatrom
GB8902424D0 (en) Medicinal formulations
GB8322826D0 (en) Physiologically active compositions
ZA846398B (en) Physiologically active compositions
GB8326753D0 (en) Physiologically active compositions
IE900393L (en) Pharmaceutical compositions for oral administration
GB8725540D0 (en) Pharmaceutically active compounds
GB8708234D0 (en) Pharmaceutically active compounds
GB8715274D0 (en) Pharmaceutically active compounds
GB8719717D0 (en) Pharmaceutically active compounds
GB8805811D0 (en) Pharmaceutically active compounds
ZA878046B (en) Pharmaceutically active compounds